Cancer Research PRL Inhibitor Induces the Cleavage of p130Cas  EMT and Cancer Progression and Treatment
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kankuri, E.
Right arrow Articles by Bizik, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kankuri, E.
Right arrow Articles by Bizik, J.
[Cancer Research 65, 9914-9922, November 1, 2005]
© 2005 American Association for Cancer Research


Cell and Tumor Biology

Induction of Hepatocyte Growth Factor/Scatter Factor by Fibroblast Clustering Directly Promotes Tumor Cell Invasiveness

Esko Kankuri1,2,3, Dana Cholujova4, Monika Comajova4, Antti Vaheri2,3 and Jozef Bizik3,4

1 Institute of Biomedicine, Pharmacology, 2 Haartman Institute, University of Helsinki; 3 Cell Therapy Research Consortium, Third Department of Surgery, Helsinki University Central Hospital, Helsinki, Finland; and 4 Laboratory of Tumor Cell Biology, Cancer Research Institute, Bratislava, Slovakia

Requests for reprints: Esko Kankuri, Institute of Biomedicine, Pharmacology, University of Helsinki, P.O. Box 63, FIN-00014 Helsinki, Finland. Phone: 358-9-191-25336; Fax: 358-9-191-25364; E-mail: esko.kankuri{at}helsinki.fi.

For determining the malignant behavior of a tumor, paracrine interactions between stromal and cancer cells are crucial. We previously reported that fibroblast clustering induces cyclooxygenase-2 (COX-2), plasminogen activation, and programmed necrosis, all of which were significantly reduced by nonsteroidal anti-inflammatory drugs (NSAID). We have now found that tumor cell–conditioned medium induces similar fibroblast clustering. Activation of the necrotic pathway in clustering fibroblasts, compared with control monolayer cultures, induced a massive >200-fold production of bioactive hepatocyte growth factor/scatter factor (HGF/SF), which made human carcinoma cells spread and invade a collagen lattice. This response occurred only if a functional, properly processed c-Met receptor was present, which was then rapidly phosphorylated. The invasion-promoting activity was inhibited by a neutralizing HGF/SF antibody. NSAIDs, if added early during fibroblast aggregation, inhibited HGF/SF production effectively but had no effect at later stages of cell aggregation. Our results thus provide the first evidence that aggravated progression of tumors with necrotic foci may involve paracrine reciprocal signaling leading to stromal activation by direct cell-cell contact (i.e., nemosis).




This article has been cited by other articles:


Home page
CVIHome page
E. Myllyluoma, A.-M. Ahonen, R. Korpela, H. Vapaatalo, and E. Kankuri
Effects of Multispecies Probiotic Combination on Helicobacter pylori Infection In Vitro
Clin. Vaccine Immunol., September 1, 2008; 15(9): 1472 - 1482.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
M. Ye, D. Hu, L. Tu, X. Zhou, F. Lu, B. Wen, W. Wu, Y. Lin, Z. Zhou, and J. Qu
Involvement of PI3K/Akt Signaling Pathway in Hepatocyte Growth Factor-Induced Migration of Uveal Melanoma Cells
Invest. Ophthalmol. Vis. Sci., February 1, 2008; 49(2): 497 - 504.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Beuret, E. Flori, C. Denoyelle, K. Bille, R. Busca, M. Picardo, C. Bertolotto, and R. Ballotti
Up-regulation of MET Expression by {alpha}-Melanocyte-stimulating Hormone and MITF Allows Hepatocyte Growth Factor to Protect Melanocytes and Melanoma Cells from Apoptosis
J. Biol. Chem., May 11, 2007; 282(19): 14140 - 14147.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2005 by the American Association for Cancer Research.